Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

A-769662

😃Good
Catalog No. T2468Cas No. 844499-71-4
Alias A 769662

A-769662 is an effective, reversible AMPK activator(EC50=0.8 μM).

A-769662

A-769662

😃Good
Purity: 99.58%
Catalog No. T2468Alias A 769662Cas No. 844499-71-4
A-769662 is an effective, reversible AMPK activator(EC50=0.8 μM).
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
2 mg$33In StockIn Stock
5 mg$52In StockIn Stock
10 mg$72In StockIn Stock
25 mg$145In StockIn Stock
50 mg$270In StockIn Stock
100 mg$489In StockIn Stock
500 mg$1,070-In Stock
1 mL x 10 mM (in DMSO)$54In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.58%
Color:White to Yellow
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
A-769662 is an effective, reversible AMPK activator(EC50=0.8 μM).
Targets&IC50
AMPK:0.8 μM(EC50)
In vitro
In ob/ob mice, A-769662 (30 mg/kg, b.i.d.) effectively reduces the hepatic expression of PEPCK, G6Pase, and FAS, decreases plasma glucose levels, and lowers triglyceride levels in both plasma and liver, thereby mitigating weight gain.
In vivo
A-769662 activates AMPK, purified from various tissues and species, in a dose-dependent manner, demonstrated across purified rat liver (EC50=0.8 μM), rat heart (EC50=2.2 mM), rat muscle (EC50=1.9 mM), and human embryonic kidney cells (HEKs) (EC50=1.1 mM). In hepatocytes, A-769662 enhances ACC phosphorylation and inhibits fatty acid synthesis, with IC50 values of 3.2 μM in primary rat hepatocytes and 3.6 μM in mouse hepatocytes. The activation of AMPK by A-769662 involves preventing the dephosphorylation at Thr-172 and structural modulation. Furthermore, A-769662 inhibits the in vitro activity of the purified 26S proteasome, as well as cell proliferation and DNA synthesis.
Kinase Assay
96-well AMPK assay: AMPK activity is measured by monitoring phosphorylation of the SAMS peptide substrate (20 mM in standard assays and 100 mM in additivity assays) following a previously described protocol (Anderson et al., 2004). To determine whether A-769662-induced AMPK activation occurs in a reversible manner, AMP or A-769662 are preincubated with rat liver AMPK for 10 minutes at 20 times standard assay concentrations prior to dilution and measurement of AMPK activity.
Cell Research
Cell viability of MEF cells treated or not with A-769662 is performed as follows: cells are harvested by trypsinization and incubated with 0.5 mg/mL RNase and 50 μg/mL propidium iodine at room temperature in the dark; cell viability is analyzed by flow cytometry using a FACScanto flow cytometer, using an excitation laser at 488 nm and a propidium iodine fluorescence detection at 600 nm. To determine the proportion of cells in each phase of the cell cycle, cells are harvested by trypsinization, collected by centrifugation, washed in PBS and fixed overnight in 80% ethanol at -20 °C. Subsequently, these fixed cells are centrifuged to remove the fixative and incubated for 20 minutes in the dark at room temperature in PBS containing 0.5 mg/mL RNase and 50 μg/mL propidium iodine. Flow cytometry analysis is performed as above. The proportion of cells in G1, S, and G2 is determined using the MODFIT program. Cell culture pictures are taken at the indicated times using a camera coupled to an inverted microscope with a 20 × objective. (Only for Reference)
SynonymsA 769662
Chemical Properties
Molecular Weight360.39
FormulaC20H12N2O3S
Cas No.844499-71-4
SmilesOc1ccccc1-c1ccc(cc1)-c1csc2[nH]c(=O)c(C#N)c(O)c12
Relative Density.1.56 g/cm3
Storage & Solubility Information
StorageIn solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
Ethanol: 3.61 mg/mL (10.02 mM), Sonication is recommended.
DMSO: 51 mg/mL (141.51 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 4.5 mg/mL (12.49 mM), Solution.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
Ethanol/DMSO
1mg5mg10mg50mg
1 mM2.7748 mL13.8739 mL27.7477 mL138.7386 mL
5 mM0.5550 mL2.7748 mL5.5495 mL27.7477 mL
10 mM0.2775 mL1.3874 mL2.7748 mL13.8739 mL
DMSO
1mg5mg10mg50mg
20 mM0.1387 mL0.6937 mL1.3874 mL6.9369 mL
50 mM0.0555 mL0.2775 mL0.5550 mL2.7748 mL
100 mM0.0277 mL0.1387 mL0.2775 mL1.3874 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy A-769662 | purchase A-769662 | A-769662 cost | order A-769662 | A-769662 chemical structure | A-769662 in vivo | A-769662 in vitro | A-769662 formula | A-769662 molecular weight